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Multiple Sequence-Specific Transcription Factors Modulate
Cytomegalovirus Enhancer Activity In Vitro
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The possibility of DNA-binding proteins interacting in vitro with the polymerase H transcriptional
machinery was explored by using a competition assay with individual target sequences for enhancer-binding
factors. Transcription factors binding to at least five specific enhancer sequences mediate the activity of the
human cytomegalovirus immediate-early 1 gene in vitro. Furthermore, our data suggest that individual
DNA-bound enhancer factors can interact with the promoter transcription complex.
The human cytomegalovirus (CMV) immediate-early 1
gene (IE1) enhancer is a strong potentiator of transcription
both in vivo and in vitro (1, 2, 10). The sequence structure of
the enhancer region, which extends from about nucleotide
-65 to -530, exhibits a highly modular complexity. We have
reported previously that five distinct sequence motifs within
the enhancer region are targets for specific nuclear proteins
(2). Here we present an approach for studying the involve-
ment of these sequence-specific DNA-binding proteins with
the transcriptional machinery. This involves the synthesis of
oligonucleotides corresponding to specific protein-binding
sites and a study of their effect in the in vitro transcription
competition assay (4, 8, 9, 12). An advantage of this ap-
proach is that it can be used to directly monitor the tran-
scriptional machinery in a crude in vitro system that upon
further fractionation might lose transcription factors, which
may go undetected. Also, the assay avoids an alteration of
the DNA sequence structure that may be important for
enhancer activity. The assay also minimizes the possibility
of competition for several proteins capable of interacting
with larger restriction fragments (2, 8, 9, 12).
In pursuit of this approach, oligonucleotides correspond-
ing to the target sequences (Fig. 1A) were synthesized and
prepared for the in vitro transcription competition assay.
The in vitro transcription assay and the preparation of HeLa
cell nuclear extract have been described previously (2). The
templates, pCMV(-524)CAT and pCMV(-65)CAT, used for
runoff analysis were a complete PvuII-HindIII restriction
enzyme digest (2). The amount of template present in each in
vitro synthesis was 300 ng per 25-,ul reaction. The nuclear
extract (6 IlI), in 21 p.l of buffer containing 12 mM HEPES(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH
7.9), 10% (vol/vol) glycerol, 1.6 mM dithiothreitol, 0.12 mM
EDTA, 60 mM KCl, 2 mM MgCl2, and 5 U of placental
ribonuclease inhibitor, was initially incubated for 10 min at
4°C with or without the appropriate competitor DNA, as
indicated. The template and nucleoside triphosphates were
subsequently added, and the in vitro synthesis was allowed
to proceed for 30 min at 30°C. The synthesized RNA was
processed and analyzed on a 4% sequencing gel as described
previously (2).
Increasing the amount of several different nonspecific
DNAs in the transcription reactions did not significantly
alter the transcriptional activity of the enhancer-containing
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template, pCMV(-524)CAT (Fig. 1B). In contrast, increas-
ing amounts of specific synthetic sequences of the individual
binding sites BS1, BS2, BS4, and BS5 resulted in a dramatic
reduction (about fivefold) of transcriptional activity of the
enhancer template in vitro, whereas the BS3 DNA showed
only a marginal decrease (Fig. 1C and D). We conclude
therefore that the individual binding sites do indeed compete
for specific regulatory factors associated with the in vitro
activity of the enhancer template. The human CMV en-
hancer element stimulates its promoter activity by 15- to
25-fold in vitro (2). In contrast, therefore, to the competition
assays involving fragments containing a number of different
binding sites (2), the individual binding sites did not reduce
the enhancer activity to the promoter level. Clearly, the
involvement of multiple transcription factors increases the
combinatorial possibilities of modulating the activity of the
enhancer element. Recognition motifs similar to the se-
quences of BS1 and BS2 have been functionally character-
ized in other enhancer elements (5, 6). Moreover, we dem-
onstrate the importance of three binding sites, BS3, BS4,
and BS5, as novel recognition sequences for specific tran-
scription factors.
To examine the effect of the enhancer-protein target
sequences with the CMV promoter element, competition
assays were carried out with the plasmid pCMV(-65)CAT,
which lacks the enhancer. Under the same conditions as
used with the enhancer template, the addition of nonspecific
DNA did not reduce but increased slightly the level of
specific transcription (Fig. 2). In the presence of DNA
containing the specific binding sites, a greater increase of
specific transcription over the level with the nonspecific
competitor was observed (Fig. 2A and B). We did not
observe this effect in competition assays with the adenovirus
major late promoter. With increasing amounts of BS2 and
BS3 DNA, the level of specific transcription remained con-
stant, whereas BS1, BS4, and BS5 increased slightly the
level of transcription to the same extent as nonspecific DNA
(Fig. 3). Additionally, the level of transcription from the
murine whey acidic protein gene promoter was not altered
with nonspecific, BS2 and BS3 DNAs but was reduced
significantly with BS4 and BS5 and was slightly increased
with BS1 (unpublished observations).
The observation that specific-enhancer-sequence-binding
transcription factors can increase CMV promoter activity is
subject to several interpretations. At this point, we cannot
exclude partial, nonspecific effects of such binding sites on
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FIG. 1. (A) The sequences of one strand of the synthetic binding
sites are shown. BS1 corresponds to the 19-base-pair (bp) repeat
element (-469 to -451); BS2 corresponds to the 18-bp repeat
element (-428 to -411); BS3 corresponds to the 17-bp repeat
element (-373 to -357) as previously described (1, 2); BS4 (-446 to
-422) corresponds to site III (2), and BS5 (-299 to -284) corre-
sponds to site I (2). The nucleotide positions in the parentheses
above refer to the location of the sequence in the human CMV IE1
enhancer with respect to the transcriptional start site. The synthetic
single-stranded oligonucleotides were treated with kinase, annealed
to the complementary oligonucleotide, and cloned into the poly-
linker ofpUC18 or pUC19. BS1 and BS2 oligonucleotides were from
B. Fleckenstein. Fragments containing the individual binding sites
were gel purified from their respective plasmids after cleaving with
EcoRI and HindlIl. (B) Effect of nonspecific DNA fragments on the
transcriptional activity of pCMV(-524)CAT (2) in an in vitro
transcription competition assay. Lane C, Transcription of
pCMV(-524)CAT template in the absence of competitor DNA;
lanes 1 through 3, effect of incubating the nuclear extract for 10 min
with increasing molar amounts (lane 1, 6 to 8; lane 2, 12 to 15; and
lane 3, 25 to 30) of nonspecific competitor DNA before adding the
template: CAT, a 250-bp XbaI-NcoI fragment (spanning chloram-
phenicol acetyltransferase gene sequences) from pCMV(-524)CAT;
PL, the EcoRI-Hindill polylinker fragment from pUC19; and
pUC/H, pUC19 DNA cut with HaeIII. The amount of competitor
DNA is expressed as a molar ratio with respect to the template. (C)
Effect of specific DNA-binding sites on the transcriptional activity
of pCMV(-524)CAT in vitro. Lane C, pCMV(-524)CAT in the
absence of competitor DNA; lanes 1 through 3, nuclear extract
incubated for 10 min with increasing molar amounts of various DNA
(molar ratio as in lanes 1 to 3 of Fig. 1B) before the template was
added. The competitor DNA used is indicated above the numbered
lanes. (D) Effect of the different competitor DNAs on in vitro
transcription of pCMV(-524)CAT, summarizing the results from
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FIG. 2. (A) Effect of nonspecific and specific sites of protein-
DNA interaction on the transcriptional activity of pCMV(-65)CAT
in vitro. The lanes are as described in the legend to Fig. IC. (B)
Quantitative effects of the different competitor DNAs on in vitro
transcription of pCMV(-65)CAT. The lines are defined in the
legend to Fig. 1D.
the transcriptional machinery associated with the promoter.
Since a defined regulatory DNA sequence can be recognized
by more than one protein, it is also possible that the binding
sites used in this experiment are able to titrate the activity of
a repressor function in connection with the promoter com-
plex. Alternatively, these binding sites could trans-stimulate
the transcription complex associated with the promoter.
Indeed, the potential for trans-stimulation is in agreement
with the looping model which mechanistically necessitates
the cooperative interactions between proteins bound to
DNA (3, 7). Interestingly, a similar increase in specific
transcription has been observed with a simian virus 40 early
promoter template missing its enhancer sequences in the
presence of certain specific enhancer fragments (12). Further
studies are in progress to distinguish between the possible
mechanisms involved.
several experiments similar to those shown in Fig. 1C. For each
experiment, quantitation was achieved by densitometric scanning of
the autoradiograms. The relative transcriptional activity of a tem-
plate is plotted as a function of increasing competitor/template molar
ratio and expressed as a percentage of its transcriptional level in the
absence of competition. The lines correspond to competition with
the following DNAs: CAT (-------), BS1 ( ), BS2
BS3 ( ), BS4 (--), and BS5 (...........). The
structures of the recombinants used as templates have been de-
scribed previously (2).
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FIG. 3. Effect of the various competitor DNAs on the level of
specific transcription from the adenovirus major late promoter. The
plasmid pSmaF (11) was linearized with HindlIl and the in vitro
transcription competition assay was performed as described in the
legend to Fig. 1, except that 8 mM MgCl2 was used. Lanes 1 and 2,
In vitro competition assays performed in the presence of 12 to 15
and 25 to 30 molar amounts, respectively, of the different DNAs.
The DNA lanes are defined as described in the legend to Fig. 1A.
We thank B. Fleckenstein for providing the BS1 and BS2 oligo-
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